Watching this thing has been like watching a pinball machine lately! Up, down, lots of movement all over the place. Seems to me that the next catalyst for this thing will be the ph 3 trial of the drug they bought vs. anything else. Am i missing something or does everyone else feel that way too?
This company has lost 40% of its value in the past several months. How can that be? Any thoughts out there? I know IBB is down 20% in bear territory but why is MDVN down so much relative to the rest of biotech? Thoughtful commentary appreciated.